Ritholtz Wealth Management’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,490
Closed -$87.6K 1110
2025
Q2
$87.6K Buy
18,490
+1,011
+6% +$4.74K ﹤0.01% 963
2025
Q1
$82.7K Sell
17,479
-33,782
-66% -$197K ﹤0.01% 908
2024
Q4
$355K Buy
51,261
+20,256
+65% +$148K 0.01% 660
2024
Q3
$180K Buy
+31,005
New +$188K 0.01% 827
2022
Q4
Sell
-13,173
Closed -$165K 719
2022
Q3
$165K Buy
+13,173
New +$157K 0.01% 672

Other funds holding SRTS

Ritholtz Wealth Management's SRTS Position: Q3 2025 in Review

Ritholtz Wealth Management sold out of Sensus Healthcare (SRTS) in Q3 2025, closing a stake of 18,490 shares — an estimated $87.6K sold.

Ritholtz Wealth Management first reported a position in SRTS in Q3 2022 and held it in 5 quarters. The position peaked at $355K in Q4 2024. 42 funds tracked by Wall St. Rank hold SRTS as of Q3 2025.

  • Ritholtz Wealth Management reported no remaining Sensus Healthcare position as of Q3 2025 after selling out during the quarter.
  • Ritholtz Wealth Management sold 18,490 Sensus Healthcare shares in Q3 2025, an estimated $87.6K.
  • Ritholtz Wealth Management first reported a position in Sensus Healthcare in Q3 2022 and held it in 5 quarters.
  • Ritholtz Wealth Management's Sensus Healthcare position peaked at $355K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held Sensus Healthcare as of Q3 2025.

Based on Ritholtz Wealth Management's 13F filing for Q3 2025, filed 28 Oct 2025.